Trials / Enrolling By Invitation
Enrolling By InvitationNCT06679972
Impact of Intrahepatic Cholestasis of Pregnancy on Neonatal Respiratory Outcomes
Intrahepatic Cholestasis of Pregnancy and the Respiratory Challenges of Bile Acids Pneumonia in Neonates (The CHOLE-RESP Trial)
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Carol Davila University of Medicine and Pharmacy · Academic / Other
- Sex
- All
- Age
- 1 Hour – 28 Days
- Healthy volunteers
- Accepted
Summary
Intrahepatic cholestasis of pregnancy is a liver condition in late pregnancy, causing itching and high bile acid levels that return to normal after birth. Babies born to mothers with this condition may have a higher risk of breathing issues. Researchers suspect bile acids might lead to a specific type of lung problem in newborns, but more studies are needed to confirm this.
Detailed description
Intrahepatic cholestasis of pregnancy is a hepatic complication that predominantly arises during the second or third trimester. It is characterized by serum bile acid levels above 10 micromol/L and persistent pruritus, which resolves after delivery. To date, it has been observed that respiratory distress syndrome occurs more frequently in neonates born to mothers with cholestasis of pregnancy, and a potential new entity, 'acute bile acid-induced pneumonia,' has been proposed, though statistical confirmation is lacking. Therefore, the investigators deem it imperative to conduct a study in the neonatal population to establish a definitive conclusion regarding neonatal pulmonary impairment secondary to maternal bile acid accumulation.
Conditions
Timeline
- Start date
- 2024-10-28
- Primary completion
- 2027-12-10
- Completion
- 2028-03-01
- First posted
- 2024-11-08
- Last updated
- 2026-02-18
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT06679972. Inclusion in this directory is not an endorsement.